Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 9/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13626490 | 0.85 | CFTR (0.49) | CFTRMEN1KMT2APOLBCYP3A4 | |
| SCHEMBL13626484 | 0.85 | CFTR (0.49) | CFTRMEN1KMT2APOLBCYP3A4 | |
| SCHEMBL13626481 | 0.85 | CFTR (0.49) | CFTRMEN1KMT2APOLBCYP3A4 | |
| SCHEMBL13626501 | 0.79 | CFTR (0.59) | CFTR | |
| SCHEMBL13626536 | 0.78 | F10 (0.42) | CFTRMEN1KMT2AGAA | |
| SCHEMBL13626522 | 0.77 | CFTR (0.40) | CFTRMEN1KMT2AGAATAS1R3 | |
| SCHEMBL13626532 | 0.75 | SMN1; SMN2 (0.45) | CFTRKMT2A | |
| SCHEMBL13626542 | 0.74 | F10 (0.43) | MEN1KMT2AGAATAS1R3TAS1R1 | |
| SCHEMBL13626535 | 0.73 | LHCGR (0.39) | CFTR | |
| SCHEMBL4558064 | 0.69 | TAS1R3 (0.60) | CFTRMEN1KMT2APOLBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612089-B2 | Tetrahydroisoquinolines as factor Xa inhibitors | PORTOLA PHARMACEUTICALS, INC. (US) | 2009-11-03 | — | — | US | disclosed |
| US-7612089-B2 | Tetrahydroisoquinolines as factor Xa inhibitors | PORTOLA PHARMACEUTICALS, INC. (US) | 2009-11-03 | — | — | US | disclosed |